cbdMD, INC. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $5M | ↓-1.9% | $-283K | ↓-1975.7% | -5.7% |
| 2025-09-30 | $5M | ↑+3.6% | — | — | — |
| 2025-06-30 | $5M | ↓-11.0% | $-895K | ↓-294.7% | -19.6% |
| 2025-03-31 | $5M | ↑+8.5% | $-481K | ↑+84.0% | -10.2% |
| 2024-12-31 | $5M | ↓-4.9% | $15K | ↑+101.5% | -1.7% |
| 2024-09-30 | $5M | ↓-20.2% | $-153K | ↑+99.0% | — |
| 2024-06-30 | $5M | ↓-15.5% | $460K | ↑+126.0% | -7.4% |
| 2024-03-31 | $4M | ↓-29.9% | $-3M | ↓-125.2% | -35.4% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 38 quarters
margin trajectory tells the operating-leverage storyGo deeper
YCBD Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyYCBD Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics